Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas

Hematology Journal

Volumn 4, Issue 2, 2003, Pages 116-120

  Franchi Rezgui, Patricia ^a   Rousselot, Philippe ^a   Espié, Marc ^a   Brière, Josette ^a   Marolleau, Jean Pierre ^a   Gisselbrecht, Christian ^a   Brice, Pauline ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Chemotherapy; Lymphomas; Pregnancy; Primary ovarian failure

Indexed keywords

ALKYLATING AGENT; ASPARAGINASE; BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CONTROLLED STUDY; CRYOPRESERVATION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FEMALE FERTILITY; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OVARY INSUFFICIENCY; RISK ASSESSMENT; STATISTICAL ANALYSIS; WHOLE BODY RADIATION;

ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS, ALKYLATING; FEMALE; FERTILITY; HODGKIN DISEASE; HUMANS; INFERTILITY, FEMALE; LYMPHOMA, NON-HODGKIN; OVARIAN FAILURE, PREMATURE; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 0038677908     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200248     Document Type: Article

References (17)

1. Sieber M, Ruffer U, Jostin A, Diehl V. Treatment of Hodgkin's disease: current strategies of the German Hodgkin's lymphoma study group. Ann Oncol 1999; 10(suppl 6):23-29.
2. Ferme C, Sebban C, Hennequin C, Diviné M, Lederlin P, Gabarre J et al. Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after 6 cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the GELA H89 trial. Blood 2000; 95: 2246-2252.
3. Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P et al. Survival benefit of high-dose therapy in poor-risk aggressive non Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol. J Clin Oncol 2000; 18: 3025-3030.
4. Tilly H, Mounier N, Lederlin P, Brière J, Dupriez B, Sebban C et al. Randomized comparison of ACVBP and mBACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH 87-1 study. J Clin Oncol 2000; 18: 1309-1315.
5. Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR et al. Effects of treatment on fertility in long term survivors of childhood or adolescent cancer. N Engl J Med 1987; 317: 1315-1321.
6. Apperley JF, Reddy N. Mechanism and management of treatment related gonadal failure in recipients of high dose chemoradiotherapy. Blood rev 1995; 9: 93-110.
7. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981; 304: 1377-1382.
8. Andrieu JM, Ochoa-Molina ME. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer 1983; 52: 435-438.
9. Donnez J, Godin PA, Qu J, Nisolle M. Gonadal cryopreservation in the young patients with gynaecologic malignancies. Curr Opin Obstet Gynecol 2000; 12: 1-19.
10. Mendenhall NP, Taylor BW, Marcus RB, Million RR. The impact of pelvic recurrence and elective pelvic irradiation on survival and treatment morbidity in early-stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1991; 21: 1157-1165.
11. Keilholz U, Korbling M, Fehrentz D, Bauer H, Hunstein W. Long term endocrine toxicity of myeloablative treatment followed by autologous bone marrow transplantation in patients with malignant lymphohematopoietic disorders. Cancer 1989; 64: 641-645.
12. André M, Brice P, Cazals D, Hennequin C, Ferme C, Kerneis Y et al. Results of 3 courses of ABVD with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II, IIIA). Hematol Cell Ther 1997; 39: 59-65.
13. Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N. LNH-84 regimen, a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 1989; 7: 1018-1026.
14. Schimmer AD, Quatermain M, Imrie K, Ali V, McCrae J, Stewart K et al. Ovarian function after autologous bone marrow transplantation. J Clin Oncol 1998; 16: 2359-2363.
15. Aisner J, Wiernik PH, Pearl P. Pregnancy outcome in patients treated for Hodgkin's disease. J Clin Oncol 1993; 11: 507-512.
16. Wüller U, Stahel RA. Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive NHL. Ann Oncol 1993; 4: 399-402.
17. Haddy BH, Adde MA, McCalla J, Domanski MJ, Datiles III M, Meehan SC et al. Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas. J Clin Oncol 1998; 16: 2070-2079.